Infusions, Intravenous
6
2
2
1
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 6 trials
100.0%
+13.5% vs benchmark
17%
1 trials in Phase 3/4
0%
0 of 1 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Validation of the Effectiveness of the CFIR - ERIC Matching Tool in Implementation Research
Digital Transformation of Continuity of Care for Peripherally Inserted Central Catheters: SpadCare Experience
Evaluation of Modafinil as a Cocaine Treatment Medication and Interactions With Cocaine - 1
Drug Interaction Study With NS2359 and Cocaine in Cocaine Experienced Volunteers - 1
Cocaine-Metyrapone Interaction Study - 1
Study Evaluating the Effect of Corticosteroids on Mylotarg® Infusion-Related Adverse Events in Patients With Leukemia